Thursday, May 30, 2013: 7:00 PM-8:30 PM
Pattern and Predictors of Change in Depressive Symptoms Over 30 Months in MS
Ipek Ensari, M.Ed, University of Illinois at Urbana-Champaign;
Robert W Motl, PhD, University of Illinois at Urbana-Champaign;
Brian M Sandroff, MS, University of Illinois at Urbana-Champaign;
Sean P Mullen, PhD, University of Illinois at Urbana-Champaign;
Edward McAuley, PhD, University of Illinois at Urbana-Champaign
Comparison of Cognitive Screening of MS Patients Using the MOCA, SDMT, and MSNQ
James Gill, BSc, Fraser Health Multiple Sclerosis Clinic;
Kanha C Shete, BSc candidate, Fraser Health Multiple Sclerosis Clinic;
Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic
Relationship Between Treatment Satisfaction and Other Patient-Reported Outcomes
Daniel Kantor, MD, Neurologique;
Neetu Agashivala, MS, Novartis Pharmaceuticals Corporation;
Stanley Li, MS, Minimax Information Services;
Ron Hashmonay, MD, Novartis Pharmaceuticals Corporation;
Peter Chin, MD, Novartis Pharmaceuticals Corporation;
Edward Kim, MD, MBA, Novartis Pharmaceuticals Corporation
Psychiatric Symptoms in Pediatric Multiple Sclerosis: A Case Series
Samuel H Hughes, BS, UT Southwestern Medical Center;
Audrey Ayres, RN, UT Southwestern Medical Center;
Paula Hardeman, PA-C, UT Southwestern Medical Center;
Allen DeSena, MD, MPH, Children's Medical Center;
Christine Castillo, PhD, Children's Medical Center;
Benjamin Greenberg, MD, MHS, Children's Medical Center;
Lana Harder, PhD, Children's Medical Center;
Donna C Graves, MD, UT Southwestern Medical Center
Cognitive Dysfunction and Its Relationship with Pseudobulbar Affect in MS Patients
Farhat Husain, MD, OKLAHOMA MEDICAL RESEARCH FOUNDATION;
Cecilie Fjeldstad, PhD, OMRF Multiple Sclerosis Center of Excellence;
Jaclyn D Rosencutter, MD, OKLAHOMA MEDICAL RESEARCH FOUNDATION;
Bobbi Lakin, BA, OKLAHOMA MEDICAL RESEARCH FOUNDATION;
Anette S Fjeldstad, Ph.D., Imaging & Neurosciences Center at Research Park;
Gabriel Pardo, MD, OKLAHOMA MEDICAL RESEARCH FOUNDATION
Health Literacy is Associated with Health Care Utilization in MS
Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba;
Amber Salter, MPH, University of Alabama at Birmingham;
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic;
Tuula Tyry, PhD, St. Joseph's Hospital and Medical Center
Patient-Reported Outcomes After Fingolimod Switch: Results By Prior Therapy
Mark Gudesblatt, MD, South Shore Neurologic Associates;
Edward Kim, MD, MBA, Novartis Pharmaceuticals Corporation;
Stanley Li, MS, Minimax Information Services;
Luigi M Barbato, MD, Novartis Pharmaceuticals Corporation;
Simrat Randhawa, MD, Novartis Pharmaceuticals Corporation;
Neetu Agashivala, MS, Novartis Pharmaceuticals Corporation
Is Locomotion Motor Imagery Preserved In Multiple Sclerosis? A Pilot Study
Andrea Tacchino, PhD, Italian MS Society, Genoa, Italy;
Ludovico Pedullà, Dr., Italian MS Society, Genoa, Italy;
Mario Alberto Battaglia, MD, University of Siena, Italy;
Erika Chiavacci, Bachelor, University of Genoa;
Giampaolo Brichetto, MD, PhD, Italian MS Society, Genoa, Italy
Disease Modifying Therapies Impact Quality of Life Differently for Women/Men Over Time
Karen VL Turpin, PhD Student, MSc, BScN, University of Alberta;
Linda J Carroll, PhD, University of Alberta;
J. David Cassidy, PhD, University of Southern Denmark;
Walter J Hader, MD, University of Saskatchewan
![[ Visit Client Website ]](images/banner.gif)